Cytek Biosciences financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

사이텍 바이오사이언시스NASDAQ:CTKB · Nasdaq · Healthcare

$5.87+1.03%

2026-10-02 close

Cytek Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $200M. 2024 operating profit was −$21M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy